ACCORD (ACcelerating COVID-19 dRug Development) is a collaboration of leading UK doctors and scientists, industry and government partners who are accelerating the country’s drug development processes from years to months to get new COVID-19 treatments into national trials.
The platform aims to get an early indication of drug treatments’ effectiveness in treating coronavirus and if positive results are seen, these drugs will advance rapidly into the large-scale trials currently in progress across the country.
ACCORD clinical academic lead Professor Tom Wilkinson commented “There has been a tremendous effort to pull this together so rapidly. ACCORD is a national effort and will be key to developing effective new treatments which are needed so desperately”.
Six potential drugs will enter the programme initially, with the first three of these beginning Phase 2 studies. Those showing promise will be fed into studies such as the RECOVERY trial, currently the world’s largest randomised controlled clinical trial for COVID-19 treatment.
University of Southampton